Official UK procurement notice
Supply of Recombinant Proteins to APHA
Authority: Defra Network eTendering Portal
What is being bought
Published requirement descriptionSupply of Recombinant Proteins to the Animal and Plant Health Agency (APHA).
CPV: Peptones and protein substances
The lotProcurement structure
single lot · no lot value publishedLot #1The requirement is for production and supply of nine (9) novel recombinant proteins in…Awarded
The requirement is for production and supply of nine (9) novel recombinant proteins in a polyhistidine tags ("His-tags") presentation (to include cloning, expression and purification).
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 8 May 2024, 09:57 BST
- Last source update
- 8 May 2024, 09:57 BST
- Authority reference
C24452- FTS notice number
2024/S 000-014613- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0457c7Find a Tender
- Why no open competition
The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the directive
- Published justification
This product is required purely for research purposes. This procurement aims to provide a small quantity of the final products (recombinant proteins, 2mg/ml in a purified state) that can be used to validate previously generated data and allow further development of serological assays. <br/><br/>An analysis of the five requirements of the Frascati guidelines have been completed and all five criteria are met for this requirement:<br/>- Novel: These required products are novel proteins that have not been previously produced or made available commercially. <br/>- Creative: Fragments identified in the discovery phase have been identified for production as full chain recombinant proteins. This is the first time these have been identified for any species.<br/>- Uncertainty of outcome: Due to the novel nature of the requirement, there is a possibility that the Supplier will not be able to produce one / more of these proteins. The production of the proteins will be challenging as there may be unknown factors that could cause the proteins to be unstable.<br/>- Systematic: The project is conducted under quality standard ISO 90001:2015. This standard requires documentation of all work, including obtaining data sheets of the procured proteins. <br/>- Transferrable: Knowledge will be fully transferable in the future and would allow an alternative supplier to re-produce the results.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| LIONEX GmbHSME | £116,420 † | — | Awarded |
Contracts
Contract 014613-2024-1 · LIONEX GmbHSME
- Signed
- 30 Apr 2024
- Value
- £116,420
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Public Procurement Review BodyMediation bodyReview body
Bidders & participating suppliers
1 commercial party on the notice- LIONEX GmbHAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.